Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for CATALYST PHARMACEUTICALS INC COMMON STOCK (CPRX).
- Disclosed ownership: 5.2%.
- Date of event: 30 Sep 2025.
STATE STREET CORP - 30 Sep 2025 SCHEDULE 13G Report for CATALYST PHARMACEUTICALS INC COMMON STOCK (CPRX)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- CPRX
- Shares outstanding
- 123,180,519 shares
- Disclosed Ownership
- 6,405,387 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Nov 2025, 08:17:56 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 5.2% ownership in CATALYST PHARMACEUTICALS INC COMMON STOCK (CPRX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Nov 2025, 08:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 5.2% | 6,405,387 | 0 | 6,034,527 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |